These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10417549)

  • 21. Mycophenolate mofetil for interstitial lung disease in scleroderma.
    Plastiras SC; Vlachoyiannopoulos PG; Tzelepis GE
    Rheumatology (Oxford); 2006 Dec; 45(12):1572. PubMed ID: 16998235
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycophenolate mofetil for Crohn's disease.
    Atherton JC
    Gut; 2000 May; 46(5):740-1. PubMed ID: 10836856
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN).
    Bullo B; Zdrojewski Z; Rutkowski B
    Kidney Int; 2003 Sep; 64(3):1139. PubMed ID: 12911571
    [No Abstract]   [Full Text] [Related]  

  • 24. Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate.
    Satchell AC; Barnetson RS
    Br J Dermatol; 2000 Jul; 143(1):202-3. PubMed ID: 10886168
    [No Abstract]   [Full Text] [Related]  

  • 25. Mycophenolate mofetil: implications for the treatment of glomerular disease.
    Badid C; Desmouliere A; Laville M
    Nephrol Dial Transplant; 2001 Sep; 16(9):1752-6. PubMed ID: 11522852
    [No Abstract]   [Full Text] [Related]  

  • 26. Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?
    Present DH
    Gut; 1999 May; 44(5):592-3. PubMed ID: 10205187
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil.
    Hatton MP; Rubin PA; Foster CS
    Am J Ophthalmol; 2005 Nov; 140(5):916-8. PubMed ID: 16310473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early onset neutropenia after mycophenolate mofetil in systemic sclerosis.
    Cuomo G; Abignano G; Valentini G
    Rheumatol Int; 2009 Oct; 29(12):1529-30. PubMed ID: 19247660
    [No Abstract]   [Full Text] [Related]  

  • 30. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
    Gilmour E; Stewart DG
    Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Agents for Severe Atopic Dermatitis in Children.
    Notaro ER; Sidbury R
    Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent.
    Yau VK; Bianco D
    J Small Anim Pract; 2014 Jun; 55(6):330-3. PubMed ID: 24602067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy.
    Leeaphorn N; Stokes MB; Ungprasert P; Lecates W
    Am J Kidney Dis; 2014 Apr; 63(4):696-9. PubMed ID: 24315767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.
    Sankatsing SU; Hoggard PG; Huitema AD; Sparidans RW; Kewn S; Crommentuyn KM; Lange JM; Beijnen JH; Back DJ; Prins JM
    Clin Pharmacokinet; 2004; 43(12):823-32. PubMed ID: 15355127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of systemic lupus erythematosus with mycophenolate mofetil.
    Adu D; Cross J; Jayne DR
    Lupus; 2001; 10(3):203-8. PubMed ID: 11315353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
    J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute tubulointerstitial nephritis associated with uveitis (TINU). Treatment of the ocular inflammation with mycophenolate mofetil].
    Sánchez Román J; Castillo Palma MJ; Ocaña Medina C; Rueda Rueda T
    Med Clin (Barc); 1998 Nov; 111(16):638. PubMed ID: 9881342
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K; Schwartz I; Itschert G; Dieck AT
    Br J Dermatol; 2000 Aug; 143(2):385-91. PubMed ID: 10951150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil.
    Surjushe A; Saple DG
    Indian J Dermatol Venereol Leprol; 2008; 74(2):180-4. PubMed ID: 18388396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.